Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Glaxosmithkline (GSK) Share Price

Price 1,910.50p on 15-07-2026 at 12:59:29
Change -10.00p -0.52%
Buy 1,911.50p
Sell 1,910.50p
Last Trade: Buy 186.00 at 1,911.0501p
Day's Volume: 1,175,865
Last Close: 1,920.50p
Open: 1,920.50p
ISIN: GB00BN7SWP63
Day's Range 1,908.00p - 1,922.00p
52wk Range: 1,315.00p - 2,282.00p
Market Capitalisation: £76.53b
VWAP: 1,914.60169p
Shares in Issue: 4.01b

Glaxosmithkline (GSK) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Buy* 186 1,911.0501p Ordinary
13:59:27 - 15-Jul-26
Unknown* 1 1,911.00p SI Trade
13:58:41 - 15-Jul-26
Sell* 75 1,910.50p Automatic Execution
13:58:20 - 15-Jul-26
Buy* 89 1,910.00p Automatic Execution
13:58:09 - 15-Jul-26
Buy* 87 1,910.00p Automatic Execution
13:58:09 - 15-Jul-26
Sell* 12 1,909.50p Automatic Execution
13:57:14 - 15-Jul-26
Unknown* 0 1,910.00p OTC Trade
13:57:08 - 15-Jul-26
Buy* 28 1,909.50p Automatic Execution
13:57:08 - 15-Jul-26
Sell* 2 1,909.50p Automatic Execution
13:57:06 - 15-Jul-26
Sell* 414 1,909.50p Automatic Execution
13:57:06 - 15-Jul-26
See more Glaxosmithkline trades

Glaxosmithkline (GSK) Share Price History

Time period:
to
Date Open High Low Close Volume
14th Jul 2026 (Tue) 1,956.00 1,957.50 1,905.00 1,920.50 4,279,605
13th Jul 2026 (Mon) 1,960.00 1,983.50 1,934.00 1,953.50 4,209,058
10th Jul 2026 (Fri) 1,963.50 1,981.00 1,954.00 1,961.50 6,365,614
9th Jul 2026 (Thu) 1,960.00 1,982.50 1,951.00 1,959.50 5,592,231
8th Jul 2026 (Wed) 1,990.50 1,990.50 1,964.00 1,979.50 4,243,160
7th Jul 2026 (Tue) 1,998.00 2,031.00 1,982.00 2,003.00 4,183,205
6th Jul 2026 (Mon) 2,025.00 2,048.00 1,967.50 1,983.00 15,157,640
3rd Jul 2026 (Fri) 2,005.00 2,015.00 1,988.00 2,015.00 2,548,103
2nd Jul 2026 (Thu) 1,949.00 2,014.00 1,943.00 2,004.00 17,566,583
1st Jul 2026 (Wed) 1,981.00 1,992.00 1,930.00 1,930.00 8,817,916
30th Jun 2026 (Tue) 1,999.50 2,009.00 1,946.50 1,981.00 13,957,667
29th Jun 2026 (Mon) 1,995.00 1,996.50 1,969.00 1,979.50 9,717,943
26th Jun 2026 (Fri) 1,972.50 1,995.50 1,945.50 1,983.00 13,837,274
25th Jun 2026 (Thu) 1,949.00 1,991.00 1,926.50 1,983.50 8,999,065
24th Jun 2026 (Wed) 1,967.00 1,984.00 1,950.00 1,950.00 5,923,852
23rd Jun 2026 (Tue) 1,915.00 1,971.00 1,911.00 1,957.50 8,305,282
22nd Jun 2026 (Mon) 1,925.00 1,931.50 1,912.00 1,924.50 3,565,700
19th Jun 2026 (Fri) 1,926.00 1,943.00 1,917.00 1,925.50 15,135,955
18th Jun 2026 (Thu) 1,976.00 1,978.50 1,906.00 1,923.00 7,565,324
17th Jun 2026 (Wed) 1,948.50 1,974.00 1,935.50 1,972.50 4,713,165
16th Jun 2026 (Tue) 1,955.50 1,968.00 1,940.50 1,950.00 6,759,168
15th Jun 2026 (Mon) 1,984.00 1,988.50 1,953.50 1,958.00 7,052,610
See more Glaxosmithkline price history

Glaxosmithkline (GSK) Regulatory News

Date Source Headline
14th Jul 2026 3:30 pm RNS Director/PDMR Shareholding
13th Jul 2026 3:30 pm RNS Director/PDMR Shareholding
13th Jul 2026 7:00 am RNS Positive Jemperli data in dMMR/MSI-H rectal cancer
10th Jul 2026 11:58 am RNS Hansoh positive Phase III results for Riz-Rez
9th Jul 2026 3:30 pm RNS Director/PDMR Shareholding
9th Jul 2026 10:00 am RNS Directorate change
1st Jul 2026 3:00 pm RNS Total Voting Rights
29th Jun 2026 3:00 pm RNS Transaction in Own Shares
29th Jun 2026 3:00 pm RNS Holding(s) in Company
26th Jun 2026 3:00 pm RNS Holding(s) in Company
See more Glaxosmithkline regulatory news

Glaxosmithkline (GSK) Share News

GSK posts encouraging data for bowel cancer treatment Jemperli

13th Jul 2026 09:32

(Alliance News) - GSK PLC on Monday reported encouraging trial data for its cancer treatment Jemperli, also known as dostarlimab. Read More

LONDON MARKET OPEN: Oil gains lift BP as Iran tensions weigh

13th Jul 2026 09:15

(Alliance News) - Stock prices in London opened slightly lower on Monday as renewed tensions between the US and Iran lifted oil prices. Read More

LONDON BRIEFING: GSK hails cancer trial success; Plus500 backs outlook

13th Jul 2026 07:59

(Alliance News) - GSK reports positive Jemperli trial data, while Plus500 posts record first-half revenue. Elsewhere, Heathrow's first-half passenger traffic edged higher despite a June decline caused by weaker Middle East travel. Read More

GSK says Ris-Rez meets primary endpoint in phase 3 lung cancer trial

10th Jul 2026 13:11

(Alliance News) - GSK PLC on Friday announced that risvutatug rezetecan has delivered "meaningful" survival data in a "pivotal" trial for advanced or relapsed small-cell lung cancer. Read More

GSK adds Royal Philips' Chief Executive Jakobs to board

9th Jul 2026 11:01

(Alliance News) - GSK PLC on Thursday announced that Roy Jakobs, the chief executive officer of Royal Philips NV, will join its board next week as a non-executive director. Read More

See more Glaxosmithkline news
FTSE 100 Latest
Value10,522.49
Change-6.90

Login to your account

Forgot Password?

Not Registered